Info
gilteritinib
- from flt3_mutation_in_aml
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML Venetoclax in Combination with Gilteritinib Demonstrates Molecular Clearance of FLT3 mutation in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia | Blood | American Society of Hematology